GlassScriptPhysician profile
Dumrong Tangchitnob
NPI 1487752374
$2,576.14
in general payments reported to CMS, 2019-2025
19 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $303 · 2021: $586 · 2022: $310 · 2023: $235 · 2024: $57.87 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $813.65 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $242.57 | 2023-2025 | Myfembree, Gemtesa |
| Avanos Medical | $234.37 | 2019-2022 | |
| Avion Pharmaceuticals | $231.16 | 2019-2021 | |
| Coopersurgical, INC. | $171.46 | 2019-2022 | |
| Novo Nordisk INC | $135.13 | 2021-2022 | |
| Inspire Medical Systems, INC. | $120.55 | 2025 | Inspire |
| Amag Pharmaceuticals, INC. | $117.22 | 2019 | |
| Olympus America INC. | $113.85 | 2021 | |
| Pfizer INC. | $72.28 | 2023-2024 | |
| Allergan, INC. | $59.02 | 2019 | |
| Therapeuticsmd, INC. | $50.46 | 2019-2021 | |
| Exeltis, USA INC. | $43.38 | 2019-2023 | Slynd |
| Currax Pharmaceuticals LLC | $41.78 | 2021 | |
| Myovant Sciences INC. | $40.58 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $32.50 | 2022 | |
| Medtronic, INC. | $25.85 | 2023 | Ligasure |
| Karl Storz Endoscopy-America | $15.87 | 2021 | |
| Hologic Sales and Service, LLC | $14.46 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dumrong Tangchitnob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.